A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive preliminary data for the safe and effective redirection of nutrient absorption into the lower intestine, the weight loss and metabolic management mechanism behind gastric bypass surgery.
Source: Medical Xpress
